Becton Dickinson to invest $19bn in US in tariff-relief deal with government

Becton Dickinson (BDX.N) plans to invest $19 billion in the United States over several years, including $3 billion to expand domestic manufacturing, as part of an agreement with the US government to strengthen the supply of essential medical products.

The medical technology company said on Tuesday that the overall commitment covers capital, operational and supply-chain investments, with the $3 billion earmarked for strategic manufacturing sites across the country.

In return, the agreement provides the company relief from future tariffs imposed under Section 232 on covered products and inputs — subject to the final scope of any tariff measures and the company meeting agreed milestones.

The deal is the latest in a series of investment-for-tariff-relief arrangements the administration has struck with major manufacturers, trading long-term domestic spending commitments for exemptions from sectoral import duties.

Sources: Reuters — Becton Dickinson to invest $19 billion in US